About this trial
This is an Open-Label, Randomized, Three-Way, Three-Arm, Crossover, Balance Study to Evaluate the Effect of Phaseolean on Glycemic response to carbohydrate rich meals in Healthy Adult Participants Using an In Vivo Method.
Eligibility criteria
Qualifiers
None
Disqualifiers
Participant has any known food allergy or intolerance to any food or beverages.
Participant is taking any medication in the past one week.
Participants should not be taking any medications known to affect glucose tolerance (excluding oral contraceptives) - stable doses of oral contraceptives, acetylsalicylic acid, thyroxin, vitamins and mineral supplements or drugs to treat hypertension or osteoporosis are acceptable
Participants should not have any known food allergy or intolerance
Trial design
Treatments tested in this trial
- Phaseolean (White Kidney Bean Extract) 1000 milligrams
- Phaseolean (White Kidney Bean Extract) 2000 milligrams
- Anhydrous Glucose Powder
- Plain white bread
Treatment groups
Locations
Sponsors and collaborators
NovoBliss Research Pvt Ltd
Lead sponsor
Ambe Phytoextracts Pvt. Ltd
Collaborator